EHJ-CVP is now fully open access as of 1 January 2025

Oxford University Press is pleased to announce that European Heart Journal-Cardiovascular Pharmacotherapy (EHJ-CVP) is now a fully open access journal beginning with the 2025 volume. All accepted submissions from 3 September 2024 will publish in the 2025 volume and therefore an Article Processing Charge may be payable as outlined below.

Find out more about the change below.

• How can I access older archived content?
• Licensing
• Article Processing Charges (APCs)
• If I cannot afford the open access fee, what are my options?

How can I access older archived content?

With the move to fully open access, all archived EHJ-CVP content will free to access starting in 2025.

Licensing

Open access articles will continue to be published under Creative Commons licenses. Authors publishing in EHJ-CVP will publish under the Creative Commons Attribution license (CC BY) or a Creative Commons NonCommercial license (CC BY-NC) for their articles.

Article Processing Charges (APCs)

If I cannot afford the open access fee, what are my options?

OUP has a growing number of Read and Publish agreements with institutions and consortia that provide funding for open access publishing. This means authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution is participating.

Waivers will be granted to scientists working in developing countries as part of OUP’s Developing Countries Initiative.

It's important to us that authors not be excluded from publishing in the journal because of a financial barrier. Applications for a waiver from authors whose APC is not covered by a Read and Publish agreement and who are not from a developing country will be considered on a case-by-case basis. We accept and respect that there are many valid reasons for an author being unable to pay the APC, and therefore waiver requests should be directed to the Author Support team at [email protected]